| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $3.8B | $4.4B | $5.2B | $3.7B | $3.0B |
| Cost of Revenue | $0.8B | $1.1B | $1.3B | $1.9B | $1.3B | $0.2B |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | $0.2B | $0.3B | $0.3B | $0.3B | $0.2B | $0.3B |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | $-0.1B | $-0.0B | $-0.3B | $-0.5B | $-0.1B | $-0.0B |
| Net Income | $-0.1B | $-0.5B | $0.3B | $-1.2B | $0.6B | $0.5B |
| EPS (Basic) | $-1.30 | $-6.49 | $3.07 | $-13.55 | $6.70 | $5.96 |
| EPS (Diluted) | $-1.30 | $-6.49 | $2.97 | $-13.55 | $6.31 | $5.59 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $7.1B | $9.5B | $10.4B | $10.4B | $12.3B | $9.1B |
| Current Assets | $1.5B | $2.5B | $2.2B | $2.6B | $3.1B | $4.1B |
| Cash & Equivalents | $1.0B | $1.8B | $1.3B | $1.4B | $2.1B | $3.5B |
| Total Liabilities | — | — | — | — | — | — |
| Current Liabilities | $0.6B | $0.9B | $1.0B | $1.1B | $1.4B | $0.8B |
| Stockholders' Equity | $4.7B | $5.6B | $6.1B | $5.9B | $7.2B | $6.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | — | $0.4B | — | — | — | $0.2B |
| Investing Cash Flow | — | $0.3B | — | — | — | $-1.9B |
| Capital Expenditures | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | — | $-0.1B | — | — | — | $4.4B |